Erica A Golemis Selected Research

Erica A Golemis Research Topics

Disease

76	Neoplasms (Cancer) 04/2022 - 01/2002
13	Neoplasm Metastasis (Metastasis) 04/2022 - 04/2008
7	Squamous Cell Carcinoma of Head and Neck 01/2022 - 08/2009
7	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2020 - 07/2013
6	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2008
6	Cysts 01/2020 - 07/2013
5	Genomic Instability 01/2021 - 01/2004
5	Aneuploidy (Aneuploid) 02/2015 - 01/2004
4	Lung Neoplasms (Lung Cancer) 04/2022 - 04/2010
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 01/2016
4	Adenocarcinoma 10/2020 - 01/2016
4	Carcinoma (Carcinomatosis) 01/2018 - 10/2002
4	Head and Neck Neoplasms (Head and Neck Cancer) 03/2017 - 12/2011
4	Epilepsy (Aura) 06/2011 - 10/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020 - 01/2017
3	Colorectal Neoplasms (Colorectal Cancer) 10/2019 - 01/2013
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2019 - 10/2016
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 12/2013
2	Carcinogenesis 01/2021 - 09/2013
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2020 - 01/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 12/2015
2	Glioblastoma (Glioblastoma Multiforme) 05/2017 - 04/2010
2	Alzheimer Disease (Alzheimer's Disease) 10/2015 - 01/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2013 - 12/2011
2	Melanoma (Melanoma, Malignant) 04/2010 - 10/2007
2	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2007 - 12/2003
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 01/2020
1	Pathologic Complete Response 01/2020
1	Inflammation (Inflammations) 01/2020
1	Malignant Pleural Effusion 06/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Ascites 01/2018

Drug/Important Bio-Agent (IBA)

50	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2002
11	Aurora Kinase AIBA 08/2020 - 09/2010
9	Pharmaceutical PreparationsIBA 01/2021 - 10/2007
8	Phosphotransferases (Kinase)IBA 01/2021 - 06/2007
8	Biomarkers (Surrogate Marker)IBA 11/2017 - 09/2009
7	Biological ProductsIBA 11/2020 - 08/2009
7	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 11/2015
6	ErbB Receptors (EGF Receptor)IBA 03/2021 - 09/2010
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2013
4	Messenger RNA (mRNA)IBA 01/2018 - 04/2008
4	Small Interfering RNA (siRNA)IBA 01/2017 - 09/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 09/2013 - 03/2007
3	STA 9090IBA 01/2021 - 09/2013
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021 - 01/2014
3	CholesterolIBA 10/2020 - 01/2013
3	MLN 8237IBA 09/2019 - 01/2015
3	Cytotoxins (Cytolysins)IBA 03/2017 - 09/2010
3	STA-12-8666IBA 01/2017 - 10/2016
3	Aurora KinasesIBA 09/2013 - 10/2005
2	Oxidoreductases (Dehydrogenase)IBA 04/2022 - 01/2013
2	EnzymesIBA 04/2022 - 10/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 09/2019
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2021 - 05/2017
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 08/2009
2	TRPP Cation ChannelsIBA 01/2020 - 01/2018
2	Estrogen ReceptorsIBA 01/2020 - 01/2017
2	Estrogens (Estrogen)FDA Link 01/2020 - 01/2017
2	p21-Activated KinasesIBA 09/2019 - 12/2003
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 10/2002
2	Cadherins (E-Cadherin)IBA 01/2018 - 01/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 10/2016
2	Drug CombinationsIBA 10/2016 - 09/2013
2	Cyclin DIBA 01/2016 - 08/2015
2	SterolsIBA 09/2015 - 01/2013
2	Dasatinib (BMS 354825)FDA Link 01/2015 - 11/2010
2	STA-2842IBA 01/2014 - 07/2013
2	AntibodiesIBA 12/2013 - 12/2011
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 06/2011 - 09/2010
2	Tumor Viral Antigens (Large T Antigen)IBA 01/2011 - 01/2004
1	GlyceraldehydeIBA 04/2022
1	PhosphofructokinasesIBA 04/2022
1	Phosphates (Orthophosphate)IBA 04/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	DNA Primase (Primase)IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	ChromatinIBA 11/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	src-Family KinasesIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	ras ProteinsIBA 01/2020
1	LigandsIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 09/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2019
1	Sclerosing Solutions (Sclerosing Agents)IBA 06/2019
1	adavosertibIBA 01/2019
1	Sunitinib (Sutent)FDA Link 01/2019
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2018

Therapy/Procedure

26	Therapeutics 01/2022 - 12/2007
5	Drug Therapy (Chemotherapy) 01/2020 - 11/2010
2	Neoadjuvant Therapy 01/2020 - 12/2015
2	Cystectomy 01/2020 - 12/2015
1	Secondary Prevention 01/2018